Gevotroline
Gevotroline is a pharmaceutical compound that has been studied for its potential therapeutic effects. It is classified as a serotonin receptor antagonist and has been investigated primarily for its potential use in treating psychiatric disorders.
Pharmacology[edit | edit source]
Gevotroline functions by blocking certain serotonin receptors, specifically the 5-HT2 receptor subtype. This action is believed to modulate the levels of serotonin in the brain, which can have various effects on mood and behavior. The compound has shown promise in preclinical studies for its potential to alleviate symptoms of depression and anxiety.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the efficacy and safety of Gevotroline. These studies have primarily focused on its use in treating major depressive disorder and generalized anxiety disorder. The results have been mixed, with some trials showing significant improvement in symptoms, while others have not demonstrated a clear benefit over placebo.
Side Effects[edit | edit source]
The side effects of Gevotroline are similar to those of other serotonin receptor antagonists. Common side effects include nausea, headache, and dizziness. More serious side effects, although rare, can include cardiovascular issues and serotonin syndrome.
Mechanism of Action[edit | edit source]
Gevotroline's primary mechanism of action involves the inhibition of the 5-HT2 receptor. By blocking this receptor, Gevotroline can alter the activity of serotonin in the brain, which is thought to contribute to its potential therapeutic effects. This mechanism is similar to that of other antidepressants and anxiolytics that target the serotonin system.
Research and Development[edit | edit source]
Gevotroline is still under investigation, and more research is needed to fully understand its potential benefits and risks. Ongoing studies are exploring its use in various psychiatric conditions, as well as its long-term safety profile.
See Also[edit | edit source]
- Serotonin receptor antagonist
- 5-HT2 receptor
- Major depressive disorder
- Generalized anxiety disorder
- Serotonin syndrome
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
